Rose‐Anne Lavergne

Author

Rose‐Anne Lavergne

Also Known As

Anne Debourgogne, Florent Morio, Nourrisson, C., R -A Lavergne, R LAVERGNE, R. Lavergne, R.-A. Lavergne, R.A. Lavergne, Rose-Anne Lavergne, Rose-anne Lavergne

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Inserm Nantes Université Cibles et Médicaments des Infections et de l'Immunité Centre Hospitalier Universitaire de Nantes Centre National de la Recherche Scientifique

About

Rose‐Anne Lavergne is an author at Inserm specializing in medicine, clinical microbiology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	552
2	Engineering	1	1	25
3	Health Sciences	1	1	25
4	Biology	1	1	23
5	Cell Biology	1	1	78

Rose‐Anne Lavergne

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis Xavier Iriart, T. Challan Belval, Judith Fillaux, American Journal of Transplantation Solid Organ RecipientsMedicineHealthcare-associated InfectionClinical EpidemiologyPatient Safety	2014	138
Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia Carlos Álvarez, Rose‐Anne Lavergne, Ferry Hagen, Scientific Reports	2017	131
Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial Laurent Mandelbrot, François Kieffer, Rémi Sitta, American Journal of Obstetrics and Gynecology Maternal ImmunizationPrenatal TherapyPediatricsMaternal HealthPlacental Transmission	2018	112
Routine Identification of Medical Fungi by the New Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight System with a New Time-Effective Strategy Xavier Iriart, Rose‐Anne Lavergne, Judith Fillaux, Journal of Clinical Microbiology Diagnostic MycologyPathologyMedical FungiFungal DiversityVitek Ms System	2012	89
Nrf2, a PPARγ Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria David Olagnier, Rose‐Anne Lavergne, Étienne Meunier, PLoS Pathogens Immune RegulationImmunologyImmune SystemImmune DysregulationInflammation	2011	78
First Description of Azole-Resistant Aspergillus fumigatus Due to TR <sub>46</sub> /Y121F/T289A Mutation in France Rose‐Anne Lavergne, Florent Morio, Loïc Favennec, Antimicrobial Agents and Chemotherapy	2015	68
Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study Benjamin Gaborit, Benoît Tessoulin, Rose‐Anne Lavergne, Annals of Intensive Care	2019	65
Home Environment as a Source of Life-Threatening Azole-Resistant <i>Aspergillus fumigatus</i> in Immunocompromised Patients: Table 1. Rose‐Anne Lavergne, Taïeb Chouaki, Ferry Hagen, Clinical Infectious Diseases	2016	57
Fungicide-driven alterations in azole-resistant<i>Aspergillus fumigatus</i>are related to vegetable crops in Colombia, South America Carlos Álvarez, Rose‐Anne Lavergne, Ferry Hagen, Mycologia	2019	42
Ultrasound features of fetal toxoplasmosis: A contemporary multicenter survey in 88 fetuses C. Codaccioni, Olivier Picone, Véronique Lambert, Prenatal Diagnosis	2020	35

Page 1